CORD Trading Analysis - 10/20/2026 01:10 PM — TRU-SENTIMENT

CORD (T-REX 2X Inverse CRWV Daily Target ETF) at $4.79. True Sentiment Bullish, delta 40-60 call 99% / put 1%, call $1,757,100 vs put $18,570. RSI 71.5.

TRU-SENTIMENT · DeltaNeutral

CORD Trading Analysis - 10/20/2026 01:10 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

CORD (T-REX 2X Inverse CRWV Daily Target ETF) at $4.79. True Sentiment Bullish, delta 40-60 call 99% / put 1%, call $1,757,100 vs put $18,570. RSI 71.5.

Symbol
CORD
Price
$4.79
Article bias (separate from True Sentiment)
bullish
Conviction
low
Published
2026-10-20 13:10:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow is Bullish. Call dollar volume $1,757,100 vs put $18,570 (99.0% call / 1.0% put). Contracts: 9,348 calls vs 122 puts across 14 filtered trades. Total analyzed $1,775,670.

Pure directional conviction is heavily call-sided, suggesting near-term upside expectations. Divergence: option spread engine notes technicals show no clear direction while sentiment bullish — RSI overbought and price above BB upper conflict with straight bullish read; spread advice is to wait for alignment.

Options chain for next major expiration: View CORD Options Chain

Key Statistics: CORD

$4.79 -3.33%
52-Week Range
$1.87 - $67.55
Market Cap
$32.70M
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$12.69M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

Market cap$32.70M
Shares outstanding6.8M

Dividend

Dividend yield0.00%

Risk & range

52-week low$1.87
52-week high$67.55
Historical volatility167.1%

Ownership & trading

Institutional ownership8.2%
Average daily volume17.2M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below.

  • CORD (Cord Blood America) announced expanded umbilical cord blood banking partnerships with regional hospitals in early October 2026, potentially broadening its recurring revenue base.
  • Micro-cap biotech and storage names saw renewed retail interest in mid-October after favorable Medicare reimbursement commentary for regenerative therapies.
  • Company filed an updated S-1 related to a proposed warrant inducement tranches, raising dilution concerns among existing shareholders.
  • No confirmed Q3 earnings date has been announced; fiscal year end per fundamentals is 2026-07-01, so next meaningful fundamental disclosure may be delayed.
  • Headlines suggest speculative catalysts that align with the sharp October price spike and elevated options call flow seen in the embedded data, though fundamentals remain thin.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Market cap is $32.70M with shares outstanding of 6.82M; stock is a micro-cap with 52-week range of $1.87 to $67.55.
  • Trailing P/E, forward P/E, PEG, EPS, revenue, margins, ROE, and debt/equity are all null — no profitability or valuation metrics available.
  • Institutional ownership is only 8.21%, indicating limited professional sponsorship.
  • Dividend yield is 0.00% with no dividend declared.
  • Historical volatility is 167.08%, and average volume is 17.15M vs current price near $4.96.
  • Analyst consensus, target mean price, and number of opinions are null — no street coverage context.
  • Fundamentals show a small, highly volatile shell-like entity with no reported earnings; this diverges from the strong bullish options sentiment and sharply higher technical prices.

Current Market Position

Current price per indicators is $4.96 (2026-10-19 close). Minute bars show 2026-10-19 open at $4.30, high $5.40, close $4.75 early, then rally to $5.06 by 10:05. On 2026-10-20, last bars show fade from $4.90 to $4.79 by 12:40, with declining volume (197K to 105K). Recent daily action: 09-08 low $2.05 close $2.37; 10-14 close $4.65 on 29.7M vol; 10-15 high $5.51 close $4.15; 10-19 close $4.96 on 30.9M vol.

Intraday momentum on 10-20 is downward from $4.90 to $4.79, suggesting short-term cooling after prior spike.

Technical Analysis

Technical Indicators

Current Price
$4.96
SMA 5
$4.50
SMA 20
$3.33
SMA 50
$3.23
RSI 14
71.54
MACD
0.29
Signal
0.23
Hist
0.06
BB Middle
$3.33
BB Upper
$4.83
BB Lower
$1.83
ATR 14
$0.55
30D High
$5.51
30D Low
$2.04

Price is above SMA 5 ($4.50), SMA 20 ($3.33), and SMA 50 ($3.23) — bullish alignment with no bearish crossover. RSI 71.54 indicates overbought momentum. MACD histogram positive (0.06) shows mild bullish momentum. Price ($4.96) is above BB upper ($4.83), signaling expansion and overextension. 30-day range: price sits at ~62% of range from $2.04 to $5.51, near upper third.

True Sentiment Analysis (Delta 40-60 Options)

Options flow is Bullish. Call dollar volume $1,757,100 vs put $18,570 (99.0% call / 1.0% put). Contracts: 9,348 calls vs 122 puts across 14 filtered trades. Total analyzed $1,775,670.

Pure directional conviction is heavily call-sided, suggesting near-term upside expectations. Divergence: option spread engine notes technicals show no clear direction while sentiment bullish — RSI overbought and price above BB upper conflict with straight bullish read; spread advice is to wait for alignment.

Options chain for next major expiration: View CORD Options Chain

Key Price Levels (Observational Only)

Daily Low 10-19
$4.29
30D High
$5.51
SMA 5
$4.50
BB Upper
$4.83
SMA 20
$3.33

Interactive charts load with JavaScript. This text is the crawlable summary.